Meloxicam
- Generic Name
- Meloxicam
- Brand Names
- Anjeso, Mobic, Qmiiz, Vivlodex
- Drug Type
- Small Molecule
- Chemical Formula
- C14H13N3O4S2
- CAS Number
- 71125-38-7
- Unique Ingredient Identifier
- VG2QF83CGL
- Background
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve various types of pain, including pain caused by musculoskeletal conditions, osteoarthritis, and rheumatoid arthritis. With a longer half-life than most other NSAIDS, it is a favorable option for those who require once-daily dosing. Meloxicam is available in oral, transdermal, and intr...
- Indication
Meloxicam is indicated for the symptomatic treatment of arthritis and osteoarthritis. In addition, it is indicated for the pauciarticular and polyarticular course of Juvenile Rheumatoid Arthritis (JRA) in patients aged 2 years old or above. Off-label uses include the treatment of dental or post-surgical pain. In addition to the above, meloxicam has also been...
- Associated Conditions
- Dental Pain, Neuropathic Pain, Osteoarthritis (OA), Pain, Inflammatory, Pauciarticular juvenile rheumatoid arthritis, Polyarticular juvenile rheumatoid arthritis, chronic or unspecified, Postoperative pain, Rheumatoid Arthritis
- Associated Therapies
- -
Pre vs Post Block in Total Knee Arthroplasty (TKA)
- First Posted Date
- 2023-08-03
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 84
- Registration Number
- NCT05974501
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
Opiate Free Multimodal Pain Pathway in Elective Foot and Ankle Surgery: A Prospective Study
- First Posted Date
- 2021-02-25
- Last Posted Date
- 2023-04-27
- Lead Sponsor
- Prisma Health-Midlands
- Target Recruit Count
- 72
- Registration Number
- NCT04771741
- Locations
- 🇺🇸
Prisma Health Midlands, Columbia, South Carolina, United States
PROUD Study - Preventing Opioid Use Disorders
- Conditions
- Interventions
- Behavioral: Guided mindfulness exercisesOther: Self-administered aromatherapyDrug: Baby aspirinDrug: Tylenol/AcetaminophenDrug: PregabalinDrug: PrednisoneDrug: MeloxicamDrug: PrilosecDrug: TramadolDrug: VoltarenDrug: ZofranDrug: PepcidDrug: ReglanDrug: VersedDrug: LidocaineDrug: PropofolDrug: AncefDrug: Tranexamic Acid (TXA)Drug: DecadronDrug: Bupivacaine hydrochlorideDrug: Toradol
- First Posted Date
- 2021-02-23
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Emory University
- Target Recruit Count
- 57
- Registration Number
- NCT04766996
- Locations
- 🇺🇸
Emory University Orthopaedic and Spine Hospital, Atlanta, Georgia, United States
Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs
- Conditions
- Interventions
- First Posted Date
- 2020-07-29
- Last Posted Date
- 2020-07-29
- Lead Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Target Recruit Count
- 110
- Registration Number
- NCT04490434
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Bawei Shenqi Pill in the Treatment of Ankylosing Spondylitis
- Conditions
- Interventions
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2020-08-14
- Target Recruit Count
- 80
- Registration Number
- NCT04480359
- Locations
- 🇨🇳
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, China
Pharmacokinetic and Tolerance Study of Meloxicam Eye Drops in Healthy Volunteers
- First Posted Date
- 2020-03-26
- Last Posted Date
- 2020-04-28
- Lead Sponsor
- Beijing Tongren Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT04322175
- Locations
- 🇨🇳
Institution of Drug Clinical Trials, Beijing, Beijing, China
Individualizing Anti-Inflammatory Medications for Adults With Axial Spondyloarthritis: A Series of N-of 1 Trials
- Conditions
- Interventions
- First Posted Date
- 2019-10-03
- Last Posted Date
- 2023-12-05
- Target Recruit Count
- 42
- Registration Number
- NCT04115098
- Locations
- 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States
The Effect of Prolonged Multimodal Analgesic Regimen on Post Hospital Discharge Opioid Use and Pain Control After Primary Total Knee Arthroplasty
- Conditions
- Interventions
- First Posted Date
- 2019-07-01
- Last Posted Date
- 2019-07-01
- Lead Sponsor
- Rothman Institute Orthopaedics
- Target Recruit Count
- 216
- Registration Number
- NCT04003350
- Locations
- 🇺🇸
Rothman Institute, Philadelphia, Pennsylvania, United States
Maximizing Outcomes in Treating Acute Migraine
- Conditions
- Interventions
- First Posted Date
- 2019-03-29
- Last Posted Date
- 2023-08-24
- Lead Sponsor
- Axsome Therapeutics, Inc.
- Target Recruit Count
- 1594
- Registration Number
- NCT03896009
- Locations
- 🇺🇸
Clinical Research Site, Seattle, Washington, United States
Multimodal Analgesia in Shoulder Arthroplasty
- Conditions
- Interventions
- First Posted Date
- 2018-07-16
- Last Posted Date
- 2021-09-28
- Lead Sponsor
- Rush University Medical Center
- Registration Number
- NCT03586934
- Locations
- 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.